NCT05261399 2025-01-10
SAFFRON
AstraZeneca
Phase 3 Recruiting
Clinical Trials
7 trialsNCT01855451 2022-11-18
HPVOropharynx
Trans Tasman Radiation Oncology Group
Phase 3 Unknown
NCT04217512 2020-01-03
Pantoprazole in Cisplatin Nephrotoxicity
Tanta University
Phase 3 Recruiting
NCT00548548 2017-06-14
AVAGAST
Genentech, Inc.
Phase 3 Completed
NCT00022178 2013-09-20
Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00126269 2006-09-08
Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Unknown
NCT00201383 2005-09-20
Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients
National Health Research Institutes, Taiwan
Phase 3 Completed